scholarly journals Determination of the obesity-associated gene variants within the entire FTO gene by ultra-deep targeted sequencing in obese and lean children

2012 ◽  
Vol 37 (3) ◽  
pp. 424-431 ◽  
Author(s):  
M Sällman Almén ◽  
M Rask-Andersen ◽  
J A Jacobsson ◽  
A Ameur ◽  
I Kalnina ◽  
...  
2012 ◽  
Vol 76 (5) ◽  
pp. 333-341 ◽  
Author(s):  
Gregory Livshits ◽  
Ida Malkin ◽  
Alireza Moayyeri ◽  
Timothy D Spector ◽  
Christopher J Hammond

2015 ◽  
Vol 47 ◽  
pp. 446
Author(s):  
Matthew B. Cooke ◽  
Jessica Danaher ◽  
Mike Greenwood ◽  
Christos G. Stathis

2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Renata Saucedo ◽  
Jorge Valencia ◽  
Claudia Gutierrez ◽  
Lourdes Basurto ◽  
Marcelino Hernandez ◽  
...  

2000 ◽  
Vol 68 (9) ◽  
pp. 4938-4947 ◽  
Author(s):  
Bachra Rokbi ◽  
Geneviève Renauld-Mongenie ◽  
Michèle Mignon ◽  
B. Danve ◽  
David Poncet ◽  
...  

ABSTRACT The distribution of the two isotypes of tbpB in a collection of 108 serogroup B meningococcal strains belonging to the four major clonal groups associated with epidemic and hyperendemic disease (the ET-37 complex, the ET-5 complex, lineage III, and cluster A4) was determined. Isotype I strains (with a 1.8-kbtbpB gene) was less represented than isotype II strains (19.4 versus 80.6%). Isotype I was restricted to the ET-37 complex strains, while isotype II was found in all four clonal complexes. The extent of the allelic diversity of tbpB in these two groups was studied by PCR restriction analysis and sequencing of 10 newtbpB genes. Four major tbpB gene variants were characterized: B16B6 (representative of isotype I) and M982, BZ83, and 8680 (representative of isotype II). The relevance of these variants was assessed at the antigenic level by the determination of cross-bactericidal activity of purified immunoglobulin G preparations raised to the corresponding recombinant TbpB (rTbpB) protein against a panel of 27 strains (5 of isotype I and 22 of isotype II). The results indicated that rTbpB corresponding to each variant was able to induce cross-bactericidal antibodies. However, the number of strains killed with an anti-rTbpB serum was slightly lower than that obtained with an anti-TbpA+B complex. None of the sera tested raised against an isotype I strain was able to kill an isotype II strain and vice versa. None of the specific antisera tested (anti-rTbpB or anti-TbpA+B complex) was able to kill all of the 22 isotype II strains tested. Moreover, using sera raised against the C-terminus domain of TbpB M982 (amino acids 352 to 691) or BZ83 (amino acids 329 to 669) fused to the maltose-binding protein, cross-bactericidal activity was detected against 12 and 7 isotype II strains, respectively, of the 22 tested. These results suggest surface accessibility of the C-terminal end of TbpB. Altogether, these results show that although more than one rTbpB will be required in the composition of a TbpB-based vaccine to achieve a fully cross-bactericidal activity, rTbpB and its C terminus were able by themselves to induce cross-bactericidal antibodies.


2017 ◽  
Vol 117 (1) ◽  
pp. 136-143 ◽  
Author(s):  
Sanjiban Chakrabarty ◽  
Vinay Koshy Varghese ◽  
Pranoy Sahu ◽  
Pradyumna Jayaram ◽  
Bhadravathi M Shivakumar ◽  
...  

Genes ◽  
2020 ◽  
Vol 11 (12) ◽  
pp. 1391
Author(s):  
Viktor Hlavac ◽  
Beatrice Mohelnikova-Duchonova ◽  
Martin Lovecek ◽  
Jiri Ehrmann ◽  
Veronika Brynychova ◽  
...  

Mutation spectra of 250 cancer driver, druggable, and actionable genes were analyzed in surgically resected pancreatic ductal adenocarcinoma (PDAC) patients who developed metachronous pulmonary metastases. Targeted sequencing was performed in DNA from blood and archival samples of 15 primary tumors and three paired metastases. Results were complemented with the determination of G12V mutation in KRAS by droplet digital PCR. The median number of protein-changing mutations was 52 per patient. KRAS and TP53 were significantly enriched in fractions of mutations in hotspots. Individual gene mutation frequencies or mutational loads accounting separately for drivers, druggable, or clinically actionable genes, did not significantly associate with patients’ survival. LRP1B was markedly mutated in primaries of patients who generalized (71%) compared to those developing solitary pulmonary metastases (0%). FLG2 was mutated exclusively in primary tumors compared to paired metastases. In conclusion, signatures of prognostically differing subgroups of PDAC patients were generated for further utilization in precision medicine.


Sign in / Sign up

Export Citation Format

Share Document